Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
No abstract available

PubMed Disclaimer

Figures

Figure 1
Figure 1
Possible combination of antihypertensive drugs: continuous green line (preferential combinations); dotted green line (acceptable combinations); dotted black line (less usual combinations); red line (unusual combinations). Modified from Mancia et al. 2013 ESH/ESC Guidelines for the management of arterial hypertension. ARB: angiotensin receptor blocker; CCA: calcium channel antagon ist; ACEI: angiotensin-converting-enzyme inhibitor.

References

    1. Sociedade Brasileira de Cardiologia. Departamento de Hipertensão Arterial VI Diretrizes brasileiras de hipertensão. Rev Bras Hipertens. 2010;17(1):4–62.
    1. Mancia G, Laurent S, Agabiti-Rosei E, Burnier M, Caulfield MJ, Cifkova R, et al. Reappraisal of Europeanguidelines on hypertension management: a European Society of Hypertension Task Force document. Blood Press. 2009;18(6):308–347. - PubMed
    1. Gradman AH, Basile JN, Carter BL, Bakris GL, American Society of HypertensionWritingGroup Combination therapy in hypertension. J Am SocHypertens. 2010;4(1):42–50. Erratum in: J AmSocHypertens. 2010;4(2):99. - PubMed
    1. ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group The AntihypertensiveandLipid-LoweringTreatmenttoPrevent Heart AttackTrial. Major outcomes in high risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: the Antihypertensive and Lipid-lowering Treatment to Prevent Heart Attack Trial (ALLHAT) JAMA. 2002;288(23):2981–2997. Erratum in JAMA. 2004;291(18):2196, JAMA. 2003;289(2):178. - PubMed
    1. Sever PS, Messerli MH. Hypertension management 2011: optimal combination therapy. Eur Heart J. 2011;32(20):2499–2506. - PubMed

MeSH terms

Substances